Petronella G Pieper
Overview
Explore the profile of Petronella G Pieper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
4659
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siegmund A, Pieper P, Bilardo C, Gordijn S, Khong T, Gyselaers W, et al.
Am Heart J
. 2021 Dec;
245:126-135.
PMID: 34902313
Female heart disease has for a long time been an underrecognized problem in the field of cardiology. With an ever-growing number of these patients getting pregnant, cardiac dysfunction during pregnancy...
2.
Girnius A, Zentner D, Valente A, Pieper P, Economy K, Ladouceur M, et al.
Heart
. 2020 Nov;
107(17):1390-1397.
PMID: 33234672
Background/objectives: Pregnancy may potentiate the inherent hypercoagulability of the Fontan circulation, thereby amplifying adverse events. This study sought to evaluate thrombosis and bleeding risk in pregnant women with a Fontan....
3.
Siegmund A, Willems T, Pieper P, Bilardo C, Gorter T, Bouma B, et al.
J Cardiovasc Magn Reson
. 2020 Jul;
22(1):52.
PMID: 32669114
Background: Maternal right ventricular (RV) dysfunction (measured by echocardiography) is associated with impaired uteroplacental circulation, however echocardiography has important limitations in the assessment of RV function. We therefore aimed to...
4.
Siegmund A, Pieper P, Mulder B, Sieswerda G, van Dijk A, Roos-Hesselink J, et al.
Int J Cardiol
. 2019 Dec;
306:152-157.
PMID: 31785953
Objective: Little is known about the course of echocardiographic parameters used for the evaluation of valvular heart disease (VHD) during pregnancy, hampering interpretation of possible changes (physiological vs. pathophysiological). Therefore...
5.
Regitz-Zagrosek V, Roos-Hesselink J, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, De Bonis M, et al.
Kardiol Pol
. 2019 Mar;
77(3):245-326.
PMID: 30912108
No abstract available.
6.
Lameijer H, Burchill L, Baris L, Ruys T, Roos-Hesselink J, Mulder B, et al.
Heart
. 2019 Feb;
105(11):873-880.
PMID: 30792240
Introduction: Studies on pregnancy risk in women with ischaemic heart disease (IHD) have mainly excluded pregnancies in women with pre-existent IHD. There is a need for better information about the...
7.
Pragt H, Pieper P, van Slooten Y, Freling H, van Dijk A, Sieswerda G, et al.
Semin Thorac Cardiovasc Surg
. 2019 Feb;
31(3):549-558.
PMID: 30731194
Most studies concerning valve replacement in congenital heart disease (CHD) focus on surgical morbidity and mortality. However, with the increased life expectancy of these patients, the focus shifts to quality...
8.
van Dissel A, Winter M, van der Bom T, Vliegen H, van Dijk A, Pieper P, et al.
Int J Cardiol
. 2018 Nov;
278:84-87.
PMID: 30449692
Objectives: In the VAL-SERVE (Valsartan in Systemic Right Ventricle) trial, three-year valsartan treatment improved systemic ventricular function only in symptomatic patients with congenitally or with an atrial switch corrected transposition...
9.
Regitz-Zagrosek V, Roos-Hesselink J, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, De Bonis M, et al.
Eur Heart J
. 2018 Aug;
39(34):3165-3241.
PMID: 30165544
No abstract available.
10.
Lameijer H, Aalberts J, Van Veldhuisen D, Meijer K, Pieper P
Thromb Res
. 2018 Jul;
169:123-127.
PMID: 30036784
Introduction: Direct oral anticoagulants (DOACs) are increasingly used for anticoagulation or prevention of thromboembolic events in conditions that may co-occur with pregnancy. However, evidence regarding efficacy and safety during pregnancy...